• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视炎症性肠病中的“饥饿肠道”假说。

Revisiting the "starved gut" hypothesis in inflammatory bowel disease.

作者信息

Colgan Sean P, Wang Ruth X, Hall Caroline H T, Bhagavatula Geetha, Lee J Scott

机构信息

Department of Medicine and the Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, USA.

Rocky Mountain Veterans Hospital, Aurora, CO, USA.

出版信息

Immunometabolism (Cobham). 2023 Jan 10;5(1):e0016. doi: 10.1097/IN9.0000000000000016. eCollection 2023 Jan.

DOI:10.1097/IN9.0000000000000016
PMID:36644501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9831042/
Abstract

Active episodes of inflammatory bowel disease (IBD), which include ulcerative colitis and Crohn's disease, coincide with profound shifts in the composition of the microbiota and host metabolic energy demand. Intestinal epithelial cells (IEC) that line the small intestine and colon serve as an initial point for contact for the microbiota and play a central role in innate immunity. In the 1980s, Roediger et al proposed the hypothesis that IBD represented a disease of diminished mucosal nutrition and energy deficiency ("starved gut") that strongly coincided with the degree of inflammation. These studies informed the scientific community about the important contribution of microbial-derived metabolites, particularly short-chain fatty acids (SCFA) such as butyrate, to overall energy homeostasis. Decades later, it is appreciated that disease-associated shifts in the microbiota, termed dysbiosis, places inordinate demands on energy acquisition within the mucosa, particularly during active inflammation. Here, we review the topic of tissue energetics in mucosal health and disease from the original perspective of that proposed by the starved gut hypothesis.

摘要

炎症性肠病(IBD)的活动期,包括溃疡性结肠炎和克罗恩病,与微生物群组成的深刻变化以及宿主代谢能量需求相吻合。排列在小肠和结肠内的肠上皮细胞(IEC)是微生物群接触的起始点,在先天免疫中起核心作用。20世纪80年代,罗伊迪格等人提出了一个假说,即IBD代表一种黏膜营养减少和能量缺乏的疾病(“饥饿肠道”),这与炎症程度密切相关。这些研究让科学界了解到微生物衍生代谢产物,特别是短链脂肪酸(SCFA)如丁酸盐对整体能量稳态的重要贡献。几十年后,人们认识到微生物群中与疾病相关的变化,即生态失调,对黏膜内的能量获取提出了过高要求,尤其是在炎症活跃期。在此,我们从饥饿肠道假说提出的原始角度回顾黏膜健康与疾病中的组织能量学主题。

相似文献

1
Revisiting the "starved gut" hypothesis in inflammatory bowel disease.重新审视炎症性肠病中的“饥饿肠道”假说。
Immunometabolism (Cobham). 2023 Jan 10;5(1):e0016. doi: 10.1097/IN9.0000000000000016. eCollection 2023 Jan.
2
Interplay of gut microbiota and host epithelial mitochondrial dysfunction is necessary for the development of spontaneous intestinal inflammation in mice.肠道微生物群与宿主上皮细胞线粒体功能障碍的相互作用是小鼠自发性肠道炎症发展所必需的。
Microbiome. 2023 Nov 17;11(1):256. doi: 10.1186/s40168-023-01686-9.
3
The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab.使用英夫利昔单抗成功治疗炎症性肠病时,肠道黏膜和粪便中的细菌总量会增加。
Microbiol Spectr. 2025 Aug 5;13(8):e0189424. doi: 10.1128/spectrum.01894-24. Epub 2025 Jul 7.
4
Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model.靶向微生物群和宿主炎性小体的抑制剂纳米低聚物在小鼠结肠炎模型中具有治疗作用。
ACS Pharmacol Transl Sci. 2024 Aug 30;7(9):2677-2693. doi: 10.1021/acsptsci.4c00102. eCollection 2024 Sep 13.
5
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
6
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
7
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
8
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测
J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.
9
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.
10
Enhancing recovery from gut microbiome dysbiosis and alleviating DSS-induced colitis in mice with a consortium of rare short-chain fatty acid-producing bacteria.用一组产生罕见短链脂肪酸的细菌来增强肠道微生物失调的恢复并缓解 DSS 诱导的结肠炎小鼠的症状。
Gut Microbes. 2024 Jan-Dec;16(1):2382324. doi: 10.1080/19490976.2024.2382324. Epub 2024 Jul 29.

引用本文的文献

1
genetically modified for purine nucleobase release promotes butyrate generation and colonic wound healing during DSS insult.经基因改造以促进嘌呤核苷碱基释放可在葡聚糖硫酸钠(DSS)损伤期间促进丁酸盐生成和结肠伤口愈合。
Gut Microbes. 2025 Dec;17(1):2490211. doi: 10.1080/19490976.2025.2490211. Epub 2025 Apr 17.
2
Plasma Bacterial Metabolites in Crohn's Disease Pathogenesis and Complications.克罗恩病发病机制及并发症中的血浆细菌代谢产物
Nutrients. 2024 Dec 28;17(1):74. doi: 10.3390/nu17010074.
3
Multimedia: multimodal mediation analysis of microbiome data.

本文引用的文献

1
Upadacitinib Was Efficacious and Well-tolerated Over 30 Months in Patients With Crohn's Disease in the CELEST Extension Study.在 CELEST 扩展研究中,乌帕替尼在 30 个月的时间里对克罗恩病患者有效且耐受良好。
Clin Gastroenterol Hepatol. 2022 Oct;20(10):2337-2346.e3. doi: 10.1016/j.cgh.2021.12.030. Epub 2021 Dec 27.
2
High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients.英夫利昔单抗和维多珠单抗治疗的炎症性肠病患者血清肌酸激酶水平升高
Inflamm Intest Dis. 2021 Aug 26;6(3):165-174. doi: 10.1159/000518264. eCollection 2021 Sep.
3
Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis.
多媒体:微生物组数据的多模态中介分析
Microbiol Spectr. 2025 Feb 4;13(2):e0113124. doi: 10.1128/spectrum.01131-24. Epub 2024 Dec 17.
4
Exposure of Colon-Derived Epithelial Monolayers to Fecal Luminal Factors from Patients with Colon Cancer and Ulcerative Colitis Results in Distinct Gene Expression Patterns.结直肠来源的上皮细胞单层暴露于结直肠癌和溃疡性结肠炎患者的肠道腔液因子中,导致其基因表达模式明显不同。
Int J Mol Sci. 2024 Sep 13;25(18):9886. doi: 10.3390/ijms25189886.
5
Physiologic hypoxia in the intestinal mucosa: a central role for short-chain fatty acids.肠黏膜的生理性缺氧:短链脂肪酸的核心作用。
Am J Physiol Cell Physiol. 2024 Oct 1;327(4):C1087-C1093. doi: 10.1152/ajpcell.00472.2024. Epub 2024 Aug 19.
6
Intestinal Epithelial Creatine Transporter SLC6A8 Dysregulation in Inflammation and in Response to Adherent Invasive Infection.肠道上皮肌酸转运蛋白 SLC6A8 在炎症和黏附侵袭性感染中的失调。
Int J Mol Sci. 2024 Jun 13;25(12):6537. doi: 10.3390/ijms25126537.
7
Why does increased microbial fermentation in the human colon shift toward butyrate?为什么人类结肠中微生物发酵增加会向丁酸盐转变?
AIMS Microbiol. 2024 May 6;10(2):311-319. doi: 10.3934/microbiol.2024016. eCollection 2024.
8
Mitochondrial function and gastrointestinal diseases.线粒体功能与胃肠道疾病。
Nat Rev Gastroenterol Hepatol. 2024 Aug;21(8):537-555. doi: 10.1038/s41575-024-00931-2. Epub 2024 May 13.
9
Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery.缺氧诱导因子-1α 与短链脂肪酸在炎症性肠病中的相互作用:揭开谜团的关键线索。
Front Immunol. 2024 Mar 28;15:1385907. doi: 10.3389/fimmu.2024.1385907. eCollection 2024.
10
multimedia: Multimodal Mediation Analysis of Microbiome Data.多媒体:微生物组数据的多模态中介分析
bioRxiv. 2024 Oct 4:2024.03.27.587024. doi: 10.1101/2024.03.27.587024.
豆甾醇通过激活丁酸-PPARγ 轴在结肠炎中恢复调节性 T 细胞/Th17 细胞的平衡。
Front Immunol. 2021 Oct 6;12:741934. doi: 10.3389/fimmu.2021.741934. eCollection 2021.
4
Associations between Cellular Energy and Pediatric Inflammatory Bowel Disease Patient Response to Treatment.细胞能量与小儿炎症性肠病患者对治疗反应的关系。
J Proteome Res. 2021 Sep 3;20(9):4393-4404. doi: 10.1021/acs.jproteome.1c00341. Epub 2021 Aug 23.
5
Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor.微生物衍生的丁酸盐是一种内源性 HIF 脯氨酰羟化酶抑制剂。
Gut Microbes. 2021 Jan-Dec;13(1):1938380. doi: 10.1080/19490976.2021.1938380.
6
Targeted H NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF.靶向核磁共振代谢组学和人类新鲜血液及血清样本的免疫表型分析可区分健康个体和接受抗 TNF 治疗的炎症性肠病患者。
J Mol Med (Berl). 2021 Sep;99(9):1251-1264. doi: 10.1007/s00109-021-02094-y. Epub 2021 May 21.
7
Creatine Supplementation for Patients with Inflammatory Bowel Diseases: A Scientific Rationale for a Clinical Trial.肌酸补充剂治疗炎症性肠病患者:临床试验的科学依据。
Nutrients. 2021 Apr 23;13(5):1429. doi: 10.3390/nu13051429.
8
The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.肠道细菌代谢物在非传染性疾病的人类免疫信号通路中的作用。
Gut Microbes. 2021 Jan-Dec;13(1):1-22. doi: 10.1080/19490976.2021.1882927.
9
Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome.纵向多组学揭示肠易激综合征潜在的亚组特异性机制。
Cell. 2020 Nov 12;183(4):1137-1140. doi: 10.1016/j.cell.2020.10.040.
10
Mitochondrial dysfunction in inflammatory bowel disease alters intestinal epithelial metabolism of hepatic acylcarnitines.炎症性肠病中的线粒体功能障碍改变了肠道上皮细胞对肝脏酰基辅酶 A 的代谢。
J Clin Invest. 2021 Jan 4;131(1). doi: 10.1172/JCI133371.